• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解对带回家的纳洛酮装置类型的偏好:对使用阿片类药物者观点的国际定性分析

UNDERSTANDING PREFERENCES FOR TYPE OF TAKE-HOME NALOXONE DEVICE: INTERNATIONAL QUALITATIVE ANALYSIS OF THE VIEWS OF PEOPLE WHO USE OPIOIDS.

作者信息

Neale Joanne, Farrugia Adrian, Campbell Aimee N, Dietze Paul, Dwyer Robyn, Fomiatti Renae, Jones Jermaine D, Comer Sandra D, Fraser Suzanne, Strang John

机构信息

National Addiction Centre, King's College London, London, UK.

Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.

出版信息

Drugs (Abingdon Engl). 2022;29(2):109-120. doi: 10.1080/09687637.2021.1872499. Epub 2021 Feb 22.

DOI:10.1080/09687637.2021.1872499
PMID:35813841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9268211/
Abstract

BACKGROUND

Take-home naloxone (THN) is provided to non-medically trained people to reverse potential opioid overdoses. There is an increasing range of effective intramuscular (IM) and intranasal (IN) naloxone devices and this paper explores the types preferred by people who use opioids, using consumer behaviour literature to interpret the findings.

METHODS

Data derive from two unconnected qualitative studies involving audio-recorded semi-structured interviews. Study 1 was conducted in the United States (n=21 users of non-medical/illicit opioids). Study 2 was conducted in Australia (n=42 users of non-medical/illicit or prescribed opioids).

FINDINGS

Most participants preferred IN naloxone. Preferences were based on the ease, speed, safety and comfort of each device and underpinned by accounts of overdose revivals as being very rushed and frightening situations. Preferences related to complex interactions between the naloxone device ('product'); the knowledge, skills, experience and attitudes of the lay responder ('consumer'), and when, where and how naloxone was to be used ('usage situation').

CONCLUSIONS

THN programs should offer choice of device when possible and nasal naloxone if resources permit. Asking people which devices they prefer and why and treating them as valued consumers of naloxone products can generate insights that improve future naloxone technology and increase THN uptake and usage.

摘要

背景

向未经医学培训的人员提供纳洛酮带回家(THN),以逆转潜在的阿片类药物过量。有效的肌肉注射(IM)和鼻内(IN)纳洛酮装置的种类越来越多,本文利用消费者行为文献来解读研究结果,探讨阿片类药物使用者更喜欢的装置类型。

方法

数据来自两项不相关的定性研究,包括音频记录的半结构化访谈。研究1在美国进行(n = 21名非医疗/非法阿片类药物使用者)。研究2在澳大利亚进行(n = 42名非医疗/非法或处方阿片类药物使用者)。

结果

大多数参与者更喜欢鼻内纳洛酮。偏好基于每种装置的易用性、速度、安全性和舒适度,并以过量复苏是非常紧急和可怕的情况为依据。偏好与纳洛酮装置(“产品”)、非专业急救者的知识、技能、经验和态度(“消费者”)以及纳洛酮的使用时间、地点和方式(“使用情况”)之间的复杂相互作用有关。

结论

THN项目应尽可能提供装置选择,如果资源允许,应提供鼻内纳洛酮。询问人们更喜欢哪种装置以及原因,并将他们视为纳洛酮产品的重要消费者,可以产生有助于改进未来纳洛酮技术并提高THN的接受度和使用率的见解。

相似文献

1
UNDERSTANDING PREFERENCES FOR TYPE OF TAKE-HOME NALOXONE DEVICE: INTERNATIONAL QUALITATIVE ANALYSIS OF THE VIEWS OF PEOPLE WHO USE OPIOIDS.了解对带回家的纳洛酮装置类型的偏好:对使用阿片类药物者观点的国际定性分析
Drugs (Abingdon Engl). 2022;29(2):109-120. doi: 10.1080/09687637.2021.1872499. Epub 2021 Feb 22.
2
Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.在紧急情况下的过量用药和携带纳洛酮回家:一项试点研究,考察在急诊科提供针对预防过量用药的“携带纳洛酮回家”的简短干预措施的可行性。
Emerg Med Australas. 2022 Aug;34(4):509-518. doi: 10.1111/1742-6723.13925. Epub 2022 Jan 12.
3
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.带离式纳洛酮试剂盒:一项针对潜在药物过量目击者的欧洲调查的态度和使用意愿结果。
Eur Addict Res. 2022;28(3):220-225. doi: 10.1159/000521197. Epub 2022 Feb 3.
4
Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.设计、实施和评估带纳洛酮回家护理模式的过量反应:对客户结果和观点的评估。
Drug Alcohol Rev. 2020 Jan;39(1):55-65. doi: 10.1111/dar.13015. Epub 2019 Nov 27.
5
An overview of take-home naloxone programs in Australia.澳大利亚带离型纳洛酮项目概述。
Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812.
6
Knowledge of Opioid Overdose and Attitudes to Supply of Take-Home Naloxone Among People with Chronic Noncancer Pain Prescribed Opioids.慢性非癌症疼痛患者对阿片类药物处方知识、阿片类药物过量及携带纳洛酮的态度。
Pain Med. 2018 Mar 1;19(3):533-540. doi: 10.1093/pm/pnx021.
7
Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.回顾性分析一家三级医院急诊科阿片类药物过量和干预措施的模式:COVID-19 的影响。
BMC Emerg Med. 2022 Apr 9;22(1):62. doi: 10.1186/s12873-022-00604-w.
8
Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.2014 - 2015年,不列颠哥伦比亚省温哥华市非法药物使用者中纳洛酮带回家的知晓、持有及使用情况
Public Health Rep. 2017 Sep/Oct;132(5):563-569. doi: 10.1177/0033354917717230. Epub 2017 Jul 27.
9
Guidance on take-home naloxone distribution and use by community overdose responders in Canada.加拿大社区过量反应者携带纳洛酮分发和使用指南
CMAJ. 2023 Aug 28;195(33):E1112-E1123. doi: 10.1503/cmaj.230128.
10
Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016-2020.鼻内携带式纳洛酮套件的使用比例和条件:2016-2020 年法国两家门诊戒毒中心的回顾性研究。
Therapie. 2022 Sep-Oct;77(5):581-584. doi: 10.1016/j.therap.2022.01.006. Epub 2022 Jan 12.

引用本文的文献

1
Naloxone dosing by non-medical first-responders at opioid overdoses: findings from a qualitative interview study.非医疗急救人员在阿片类药物过量时使用纳洛酮的情况:一项定性访谈研究的结果
Harm Reduct J. 2025 Apr 18;22(1):58. doi: 10.1186/s12954-025-01203-1.
2
Community pharmacy's role in dispensing androgens and supporting harm reduction amid current policy dilemmas.社区药房在当前政策困境下分发雄激素及支持减少危害方面的作用。
Subst Abuse Treat Prev Policy. 2025 Jan 18;20(1):2. doi: 10.1186/s13011-025-00636-y.
3
[Not Available].[无可用内容]。
CMAJ. 2023 Oct 3;195(38):E1312-E1325. doi: 10.1503/cmaj.230128-f.
4
Guidance on take-home naloxone distribution and use by community overdose responders in Canada.加拿大社区过量反应者携带纳洛酮分发和使用指南
CMAJ. 2023 Aug 28;195(33):E1112-E1123. doi: 10.1503/cmaj.230128.
5
Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process.州级纳洛酮获取政策的有效性和可实施性:在线修改德尔菲法的专家共识。
Int J Drug Policy. 2021 Dec;98:103383. doi: 10.1016/j.drugpo.2021.103383. Epub 2021 Jul 30.
6
Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities.纳洛酮在国家阿片类药物危机中的作用——过去的斗争、当前的努力和未来的机会。
Transl Res. 2021 Aug;234:43-57. doi: 10.1016/j.trsl.2021.03.001. Epub 2021 Mar 5.

本文引用的文献

1
Iterative categorisation (IC) (part 2): interpreting qualitative data.迭代分类法(IC)(第二部分):解释定性数据。
Addiction. 2021 Mar;116(3):668-676. doi: 10.1111/add.15259. Epub 2020 Oct 29.
2
Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.通过带回家的纳洛酮从阿片类药物过量中复苏的人群中与戒断症状和愤怒相关的因素:探索性混合方法分析。
J Subst Abuse Treat. 2020 Oct;117:108099. doi: 10.1016/j.jsat.2020.108099. Epub 2020 Aug 5.
3
Addiction stigma and the production of impediments to take-home naloxone uptake.成瘾污名化以及阻碍携带式纳洛酮获取的因素的产生。
Health (London). 2022 Mar;26(2):139-161. doi: 10.1177/1363459320925863. Epub 2020 Jun 12.
4
FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone.FDA 倡议为非处方纳洛酮药物事实标签。
N Engl J Med. 2020 May 28;382(22):2129-2136. doi: 10.1056/NEJMsa1912403.
5
Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial.纳洛酮经鼻与肌内给药对阿片类药物过量的疗效:一项随机临床试验。
JAMA Netw Open. 2019 Nov 1;2(11):e1914977. doi: 10.1001/jamanetworkopen.2019.14977.
6
Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine.带药纳洛酮:急诊医学在阿片类药物过量急救管理中的公共卫生应用
Drugs. 2019 Sep;79(13):1395-1418. doi: 10.1007/s40265-019-01154-5.
7
Take-home naloxone and the politics of care.纳洛酮带回家计划与关怀政治。
Sociol Health Illn. 2019 Feb;41(2):427-443. doi: 10.1111/1467-9566.12848.
8
Pharmacokinetics of a novel, approved, 1.4-mg intranasal naloxone formulation for reversal of opioid overdose-a randomized controlled trial.一种新型、已批准的 1.4 毫克经鼻纳洛酮制剂用于逆转阿片类药物过量的药代动力学:一项随机对照试验。
Addiction. 2019 May;114(5):859-867. doi: 10.1111/add.14552. Epub 2019 Feb 15.
9
How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.使用阿片类药物的人应对过量的能力如何?对过量紧急情况下采取的行动和决策的定性分析。
Addiction. 2019 Apr;114(4):708-718. doi: 10.1111/add.14510. Epub 2018 Dec 28.
10
Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.在基层医疗环境中开具纳洛酮处方的可接受性和可行性:系统评价。
Prev Med. 2018 Sep;114:79-87. doi: 10.1016/j.ypmed.2018.06.005. Epub 2018 Jun 15.